Cancer Research AACR Legacy Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
[Cancer Research 65, 2505, March 15, 2005]
© 2005 American Association for Cancer Research

STAT3, TFF3, VEGFR in Colon Cancer Cells

In the article on STAT3, TFF3, VEGFR in colon cancer cells in the January 1, 2005, issue of Cancer Research (1), the first and last names of the contributors were transposed. The list of authors should have read Christine Rivat, Sylvie Rodrigues, Erik Bruyneel, Genevieve Piétu, Amelie Robert, Gerard Redeuilh, Marc Bracke, Christian Gespach, and Samir Attoub. The affiliation for Drs. Rivat, Rodrigues, Redeuilh, Gespach, and Attoub is now designated as INSERM U673. The affiliation for Dr. Bracke should have been Laboratory of Experimental Cancerology, University Hospital, Gent, Belgium. The correct corresponding author information is as follows: Dr. Samir Attoub, INSERM U673, Hôspital Saint–Antoine, 75571 Paris Cedex 12, France. Phone 33-1-49284648; Fax: 33-1-44749318; E-mail: attoub{at}st-antoine.inserm.fr.

References

  1. Rivat C, Rodrigues S, Bruyneel E, Piétu G, Robert A, Redeuilh G, Bracke M, Gespach C, Attoub S. Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3)- and vascular endothelial growth factor-mediated cellular invasion and tumor growth. Cancer Res 2005;65:195–202.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online